Travere Therapeutics
TVTX
$5.60
Share price
2.56%
Change (1 day)
-75.23%
Change (1 year)
Categories
Travere Therapeutics (TVTX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.58 B
According to Travere Therapeutics's latest financial reports the company's total liabilities are $0.58 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Travere Therapeutics - Total liabilities on balance sheet (from 2011 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.58 B | -6.61% |
| 2022-12-31 | $0.62 B | 32.71% |
| 2021-12-31 | $0.47 B | 19.76% |
| 2020-12-31 | $0.39 B | 3.29% |
| 2019-12-31 | $0.38 B | -1.87% |
| 2018-12-31 | $0.39 B | 72.05% |
| 2017-12-31 | $0.22 B | 4.46% |
| 2016-12-31 | $0.21 B | 2.46% |
| 2015-12-31 | $0.21 B | 22.91% |
| 2014-12-31 | $0.17 B | 330.02% |
| 2013-12-31 | $40.16 M | 592.62% |
| 2012-12-31 | $5.79 M | |
| 2012-02-29 | $0.06 M | |
| 2011-02-28 | $0.06 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.62 B | 5.85% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $12.01 M | -97.96% | 🇺🇸 USA |